Pricing
Pricing Built for Fiduciary Accountability
Pricing
We price on governance responsibility, risk exposure, and lifecycle accountability.
-
Purpose: A "Deep-Dive" into your India strategy before you sign an MSA.
-
Deliverable: A Risk-Score Map of your chosen vendors and a Technical Feasibility Roadmap.
-
Best for: Pre-deal due diligence and portfolio triage.
Model 1: The Diagnostic Audit (Fixed Fee)
-
Purpose: Your Virtual India Office. Permanent, on-ground scientific stewardship.
-
Includes: Unannounced site visits, Real-time Risk Dashboards, talent-turnover monitoring, and crisis intervention.
-
Economic Value: Replaces the need for a $300k+ local headcount while providing independent oversight.
Model 2: Continuous Intelligence™ (Strategic Retainer)
-
Purpose: Success-linked oversight for high-risk transitions.
-
Focus: Tech Transfer, Method Validation, PPQ Batches, and PAI Readiness.
-
The Gating Logic: Payments are structured around the technical success of the program, aligning Aventiq’s incentives directly with your timelines
Model 3: Milestone-Gated Governance (Project-Based)
-
Purpose: Deep-partnership models for breakthrough therapies (ADCs, CAR-T).
-
Focus: Shared accountability for regulatory success and timeline protection.
Model 4: Performance-Linked Risk-Sharing (Selective)
-
Purpose: Provides pharma and biotech clients with a scientifically rigorous, ready-to-present intelligence package on any small molecule, biologic,
or advanced modality — without requiring in-house literature infrastructure or prolonged timelines. -
Deliverable: An intelligence dossier with annotated pathway maps, safety signals, trial data, and a structured reference matrix
-
Best for: BD and licensing teams evaluating new assets, medical/scientific teams preparing IND or CTA briefings, portfolio committees conducting asset triage,
and early-stage biotech firms without dedicated literature or biology functions.